COMP and cancer: Furthermore, in the entire cohort, COMP expression by cancer cells served as a prognostic marker of shorter OS (p = 0.015) and RFS (p = 0.027), independently of PD-L1 expression on cancer cells and immune cells, PD-1 expression on immune cells, and MMR status (Table 3).